↗4 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$3.6MBought on the market
$0.00Sold on the market
1Companies
Oct 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202621:16 | Sep 30, 2026 | HELPHelus Pharma Inc. | Director | A · Grant | — | +248,000 | 4,713,014 | +6% | — | ||
| Sep 11, 202609:01 | Sep 8, 2026 | HELPHelus Pharma Inc. | Executive Chair, Director | P · Buy | $12.39 | +100,000 | 4,465,014 | +2% | +$1.2M | -11.4% | -11.9% |
| Sep 10, 202606:21 | Sep 4, 2026 | HELPHelus Pharma Inc. | Executive Chair, Director | P · BuyLate 6d | $12.09 | +100,000 | 4,365,014 | +2% | +$1.2M | -13.6% | -9.8% |
| Sep 9, 202617:47 | Sep 1, 2026 | HELPHelus Pharma Inc. | Executive Chair, Director | P · BuyLate 8d | $11.81 | +95,000 | 4,265,014 | +2% | +$1.1M | -15.6% | -7.6% |